A

Alphatec Spine

Develops and markets spinal surgery solutions

Senior Associate Product Manager - Alignment & Surgical Planning

Full-TimeUpdated on 10/23/2026
$75k - $95k/yr
Mid
Bachelor's
Carlsbad, CA, USA
In PersonOn-site in Carlsbad; travel up to 15–40% as required.
ProductProduct Management
No H1B Sponsorship

About the job

Requirements
  • Translate customer needs into product requirements.
  • Work effectively with cross-functional teams, including engineering, marketing, sales, clinical, regulatory, quality, and research.
  • Use analytical skills and data to inform decisions.
  • Communicate effectively orally and in writing.
  • Collaborate with software development teams.
  • Organize and prioritize workflow to meet established timeframes.
  • Manage multiple tasks within a cross-functional team and in a fast-paced environment.
  • Pay strong attention to detail.
  • Represent the company professionally and competently at business functions or situations.
  • Prepare sales forecasts.
  • Work under pressure.
  • Hold a bachelor’s degree in Marketing, Software Engineering, or a related field.
  • Have 3+ years of related experience, or an equivalent combination of education and experience; technology products and/or the orthopedic device industry, especially spine, are preferred.
Responsibilities
  • Own assigned portions of the EOS Insight portfolio, driving product strategy, development, commercialization, lifecycle management, feature enhancements, and end-of-life planning.
  • Partner with leadership to define product vision, roadmap priorities, and feature sequencing aligned with business objectives, market opportunities, and customer needs.
  • Translate surgeon feedback, clinical workflows, market insights, business priorities, and technical constraints into product requirements, user stories, and development priorities.
  • Lead cross-functional collaboration with Systems Engineering, Software Engineering, Clinical, Regulatory, Quality, UX/UI, Marketing, Operations, and Commercial teams to deliver product initiatives.
  • Serve as a subject matter expert for EOS Insight and related data-driven technologies, providing guidance and support to internal stakeholders and customers.
  • Conduct customer discovery through direct engagement with surgeons, sales leaders, clinical teams, and other stakeholders to identify unmet needs and innovation opportunities.
  • Contribute to product roadmaps, business cases, market assessments, and competitive analyses to support strategic decisions.
  • Define and champion data-driven capabilities, including AI-enabled insights, analytics, predictive models, and clinical decision-support tools that enhance surgeon workflows and patient outcomes.
  • Ensure AI-enabled solutions are clinically relevant, explainable, compliant, user-centric, and aligned with surgeon decision-making and workflow requirements.
  • Partner with EOS Clinical Account Managers, Regional Sales Managers, and Market Development teams to drive product adoption, customer engagement, utilization, and commercial growth.
  • Develop sales tools, customer-facing materials, product demonstrations, training programs, case studies, and educational resources to support commercialization.
  • Coordinate and support product launches, customer onboarding, surgeon education programs, conferences, cadaver labs, trade shows, and market development activities.
  • Monitor product performance indicators, including adoption rates, utilization trends, customer satisfaction, workflow efficiency, data quality, and commercial outcomes, and recommend improvements.
  • Evaluate market trends, competitive offerings, emerging technologies, and customer feedback to identify future product opportunities and inform strategic planning.
  • Build relationships with surgeon customers, key opinion leaders, and internal stakeholders to support product development, validation, and market adoption.
  • Expand professional and technical expertise through industry engagement, independent research, professional networking, conferences, educational programs, and industry events.
  • Travel up to 15–40% as required.
  • Perform other assigned duties.
Desired Qualifications
  • Experience in spine, orthopedics, medical imaging, surgical planning, navigation, robotics, digital surgery, or AI-enabled healthcare software.
  • Experience working with web or mobile software platforms.
  • Familiarity with software as a medical device, regulated product development, design controls, usability engineering, or medical device quality systems.
  • Experience developing product requirements, user stories, launch plans, sales collateral, training materials, or product positioning.

About the company

A

Alphatec Spine

View
Website

Alphatec Spine develops and sells implants, instruments, and integrated technologies for spine surgery, including devices used in fusion procedures and related navigation or imaging systems gained through acquisitions like SafeOp Surgical. During surgery, surgeons use these implants and instruments, often with imaging or navigation tools to plan and guide the procedure, while the implants support fusion and healing. It differentiates itself with a broad product portfolio and enhanced technology through strategic acquisitions, giving it capabilities in navigation and advanced spine solutions beyond a narrow line of implants. Its goal is to improve spinal surgery outcomes and expand access to effective spine-care solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Carlsbad, California

Founded

1990

Get referred to Alphatec Spine

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $213.5 million, up 15% year over year.
  • Adjusted EBITDA rose 53% to $36 million, lifting margin to 17%.
  • May 2026 refinancing extended maturities to 2031 and cut interest expense $6 million.

What critics are saying

  • May 2026 EOS revenue missed expectations; installations failed, triggering a 32% stock drop.
  • Kirby McInerney, Pomerantz, and others investigate potential securities fraud after the May 5 disclosure.
  • With $685 million debt, another EOS stall can force dilutive financing before 2030.

What makes Alphatec Spine unique

  • ATEC combines EOS imaging, Valence robotics, SafeOp neuromonitoring, and patient-specific planning.
  • Tommy Carls joined September 2026 to unify InformatiX across imaging, analytics, and surgery.
  • Its procedural ecosystem ties preoperative planning directly to intraoperative execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Disability Insurance
  • Stock Options

Growth & Insights and Company News

6 month growth

7%

1 year growth

6%

2 year growth

6%
Yahoo Finance
Oct 18th, 2026
Alphatec shares down 49.6% this year, but DCF model suggests 48% undervaluation

Alphatec Holdings shares have fallen 49.6% so far this year to $10.46, raising the question of whether the spinal surgery company's cash generation supports its valuation. Over the last twelve months, the company's free cash flow was about negative $35 million. Analysts expect it to turn positive and grow, with projections rising from the late 2020s onward. A two-stage discounted cash flow model based on those forecasts puts Alphatec's intrinsic value well above the current price. The headline estimate is that the stock is 48% undervalued. One community narrative on Simply Wall St is more cautious, putting the stock at 13% undervalued. It warns that cost pressures and lower-cost rivals could erode pricing power and margins.

SPINEMarketGroup
Sep 24th, 2026
ATEC appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy.

ATEC appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy. Accomplished spine executive to advance ATEC's InformatiX strategy CARLSBAD, Calif.-(BUSINESS WIRE)-Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member of ATEC's Senior Leadership Team. In this newly created role, Carls will lead ATEC's development and marketing efforts across EOSedge, EOS Insight, data acquisition and analytics, and the broader InformatiX strategy. His mandate is to focus priorities, connect global teams and capabilities, and accelerate an integrated strategy that turns information about each patient and procedure into actionable clinical insight. "I have known and trusted Tommy for nearly 30 years," said Miles. "He has spent his career translating complex clinical needs into technologies that meaningfully advance spine surgery. Tommy is a student of spine. His depth of experience across implants, enabling technologies, imaging, software and clinical strategy makes him uniquely qualified to lead this next phase of our evolution. I am confident Tommy will help us accelerate the use of data and predictive analytics to make spine surgery better informed, more reproducible and personalized." ATEC has assembled a procedural ecosystem spanning EOS imaging, EOS Insight, surgical planning, Valence navigation and robotics, SafeOp neuromonitoring, and patient-specific solutions. By connecting those capabilities through InformatiX, ATEC intends to apply data and predictive analytics to inform decisions before, during and after surgery, improve the reproducibility of surgical execution, and create a learning system that advances spine care over time. Carls brings more than 3 decades of leadership and innovation experience in spine and medical technology. Throughout his career, Carls has helped develop and launch market-leading technologies across spinal implants, enabling technologies, image-guided surgery and robotics. He previously served as Vice President of Product and Clinical at Proprio Vision, where he helped advance an artificial intelligence-enabled surgical navigation platform. Before Proprio, Carls spent more than two decades with Sofamor Danek and Medtronic in numerous executive roles, spanning engineering, product development, marketing and global research and development. He holds more than 80 patents. Carls earned a Bachelor of Science degree in mechanical engineering from Tulane University and a Master of Business Administration from the University of Memphis. "ATEC has assembled a distinctive set of technologies across imaging, procedural planning, navigation and robotics, neuromonitoring, and patient-specific solutions," Carls said. "The opportunity is to connect those capabilities and apply data and predictive analytics, so a patient-specific plan becomes a shared source of truth across the continuum of care. This will inform better decisions, improve execution and create a learning system that advances outcomes over time. I am excited to join Pat and the high-performing ATEC team, to help bring that vision to life." About Alphatec Holdings Inc. ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC's Organic Innovation Machine(TM) is focused on developing new approaches that integrate seamlessly with the Company's expanding InformatiX(TM) platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC's vision is to be the Standard Bearer in Spine. For more information, visit www.atecspine.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Forward-looking statements include, among other things, statements regarding the Company's strategy; the integration of its technologies, teams and capabilities; the use of data and predictive analytics; and the anticipated clinical or commercial benefits of its InformatiX platform and procedural ecosystem. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Important factors include the Company's ability to execute its strategic operating plan, develop and integrate new products and technologies, obtain and maintain regulatory clearances or approvals, achieve surgeon acceptance, protect intellectual property, manage product liability and litigation exposure, and address other risks described in the Company's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Contacts. Investor and Media Contact Robert Judd Investor Relations (760) 494-6790 [email protected]

Business Wire
Sep 23rd, 2026
ATEC appoints Tommy Carls to lead data intelligence and InformatiX strategy

Alphatec Holdings has appointed Tommy Carls as executive vice president of data intelligence and strategy. Carls will report to chief executive officer Pat Miles and join the company's senior leadership team. In this newly created role, Carls will lead ATEC's development and marketing efforts across EOSedge, EOS Insight, data acquisition and analytics, and the broader InformatiX strategy. His focus will be connecting global teams and turning patient and procedure information into actionable clinical insight. Carls brings over 30 years of experience in spine and medical technology. He previously served as vice president of product and clinical at Proprio Vision and spent more than two decades at Sofamor Danek and Medtronic. He holds more than 80 patents.

Yahoo Finance
Sep 14th, 2026
Alphatec surges 19.7% on Q2 results, expects $882M revenue for 2026

Alphatec shares surged 19.7% to $10.58, driven by investor optimism following strong second-quarter 2026 results. The medical equipment company reported earnings per share of 7 cents and revenues of $213.5 million for the quarter. The company maintains its full-year 2026 revenue guidance of approximately $882 million, supported by strong case volume growth, increased surgeon adoption, expanding profitability and positive free cash flow generation. For the upcoming quarter, Alphatec expects earnings of $0.11 per share, representing a 266.7% year-over-year increase. Revenues are projected at $224.28 million, up 14.1% from the prior year. However, the consensus earnings estimate has remained unchanged over the past 30 days. The stock currently carries a Zacks Rank #3 (Hold).

Yahoo Finance
Aug 5th, 2026
Alphatec delivers $214M revenue and 53% adjusted EBITDA growth despite biologics headwinds

Alphatec Holdings reported strong Q2 2026 results with total revenue of $214 million, up 15% year-over-year, and surgical revenue of $196 million, up 17%. The medical device company saw adjusted EBITDA rise 53% to $36 million, with margins expanding 420 basis points to 17%. The company added 24% more net new surgeons and posted 20% case volume growth. Gross margin improved 260 basis points to 72.5%, driven by better inventory efficiency and favourable product mix. Alphatec generated positive free cash flow of approximately $1 million in Q2 and raised full-year adjusted EBITDA guidance to $140 million from $134 million previously. However, revenue per case declined 2.7% due to case mix shifts and international growth. The company now expects full-year revenue per case to decline in the low single digits, citing slower biologics attachment improvement.